MCD vs VRCA · P/E 23, rev $25.92B vs rev $7.6M
McDonald’s Corporation (MCD) versus Verrica Pharmaceuticals Inc (VRCA) — a side-by-side from cached financials, not a winner call.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Latest reported VRCA revenue for 2024-12-31 was $7.6M. Net income was -$76.6M. Revenue was up 47.7% from 2023-12-31 to 2024-12-31. VRCA currently screens at market cap $79.7M.
MCD currently screens at market cap $201.66B and trailing P/E 23.4. VRCA currently screens at market cap $79.7M.
Not investment advice. Open the MCD and VRCA stock pages for the full models.
Not investment advice.